- Home
- GMM vs TGTX Comparison
GMM vs TGTX Comparison
Compare GMM & TGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMM
- TGTX
- Stock Information
- Founded
- GMM 2017
- TGTX 1993
- Country
- GMM China
- TGTX United States
- Employees
- GMM N/A
- TGTX 264
- Industry
- GMM
- TGTX Biotechnology: Pharmaceutical Preparations
- Sector
- GMM
- TGTX Health Care
- Exchange
- GMM Nasdaq
- TGTX Nasdaq
- Market Cap
- GMM N/A
- TGTX 5.4B
- IPO Year
- GMM 2023
- TGTX 1995
- Fundamental
- Price
- GMM $0.27
- TGTX $34.55
- Analyst Decision
- GMM
- TGTX Strong Buy
- Analyst Count
- GMM 0
- TGTX 6
- Target Price
- GMM N/A
- TGTX $37.67
- AVG Volume (30 Days)
- GMM 9.7M
- TGTX 4.4M
- Earning Date
- GMM 07-23-2024
- TGTX 11-04-2024
- Dividend Yield
- GMM N/A
- TGTX N/A
- EPS Growth
- GMM N/A
- TGTX N/A
- EPS
- GMM 0.60
- TGTX N/A
- Revenue
- GMM $33,985,284.00
- TGTX $264,790,000.00
- Revenue This Year
- GMM N/A
- TGTX $43.74
- Revenue Next Year
- GMM N/A
- TGTX $64.30
- P/E Ratio
- GMM $0.46
- TGTX N/A
- Revenue Growth
- GMM 59.78
- TGTX 39.53
- 52 Week Low
- GMM $0.22
- TGTX $12.30
- 52 Week High
- GMM $15.40
- TGTX $36.50
- Technical
- Relative Strength Index (RSI)
- GMM 36.14
- TGTX 68.82
- Support Level
- GMM $0.22
- TGTX $28.59
- Resistance Level
- GMM $0.32
- TGTX $36.50
- Average True Range (ATR)
- GMM 0.05
- TGTX 2.67
- MACD
- GMM 0.00
- TGTX 0.34
- Stochastic Oscillator
- GMM 23.58
- TGTX 85.64
About TGTX TG Therapeutics Inc.
TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. The company has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS). and the company is developing TG-1701 (BTK inhibitor) and TG-1801 (anti-CD47/CD19 bispecific mAb) for B-cell disorders which are under Phase 1 trial.